Skip to main content
GaldermaLinkedIn

Galderma announces EU approval for Restylane Shaype, a new hyaluronic acid injectable for facial shaping.

Source

LinkedInAug 11, 2026
likes
99
comments
1

Post

Restylane® Shaype™ is now approved in the European Union for chin augmentation, the first-and-only bone-mimicking hyaluronic acid injectable for facial shaping. Powered by NASHA HD™ technology, Restylane Shaype is designed for deep injection to build and shape on bone, enabling natural-looking structural enhancement without surgery. It marks the latest innovation in Galderma’s Restylane portfolio – the world’s most diverse range of hyaluronic acid injectables. Learn more about the approval: https://lnkd.in/e4g75EG3 Always consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products.

linkedin.com/posts/galderma-_restylane-shaype-is-now-approved-in-the-...Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

The full record

From the Signal API record

Topics and mentions

Tags

  • Product Launch
  • Medical Research
  • Pharmaceuticals
  • Branding

Initiatives

  • launching new hyaluronic acid injectable for facial shaping

Technologies named

  • NASHA HD™ technology

Extraction

Detected
Aug 13, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Galderma and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Galderma this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6a124e7a-d788-48c2-a951-f1d0355ee011 returns this record as JSON. POST /v1/companies/enrich returns every signal for galderma.com.

{
  "signal_id": "6a124e7a-d788-48c2-a951-f1d0355ee011",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-08-13T10:39:10.995+00:00",
  "company": {
    "name": "Galderma",
    "domain": "galderma.com"
  },
  "data": {
    "tags": [
      "Product Launch",
      "Medical Research",
      "Pharmaceuticals",
      "Branding"
    ],
    "summary": "Galderma announces EU approval for Restylane Shaype, a new hyaluronic acid injectable for facial shaping.",
    "post_url": "https://www.linkedin.com/posts/galderma-_restylane-shaype-is-now-approved-in-the-activity-7492808969216876544-m795",
    "num_likes": 99,
    "post_text": "Restylane® Shaype™ is now approved in the European Union for chin augmentation, the first-and-only bone-mimicking hyaluronic acid injectable for facial shaping.\n\nPowered by NASHA HD™ technology, Restylane Shaype is designed for deep injection to build and shape on bone, enabling natural-looking structural enhancement without surgery. \n\nIt marks the latest innovation in Galderma’s Restylane portfolio – the world’s most diverse range of hyaluronic acid injectables.\n\nLearn more about the approval: https://lnkd.in/e4g75EG3\n\nAlways consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products.",
    "initiatives": [
      {
        "topic": "launching new hyaluronic acid injectable for facial shaping",
        "urgency": 0.8
      }
    ],
    "posted_date": "2026-08-11T05:07:47.920Z",
    "num_comments": 1,
    "technologies_mentioned": [
      {
        "name": "NASHA HD™ technology",
        "status": "used_in_product"
      }
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.